Safety Tolerability and Pharmacokinetics of OnceMonthly Oral Islatravir a Phase 2a Study in Participants at Low Risk for Acquiring HIV1

dc.article.end-page1060en
dc.article.start-page1050en
dc.citation.doi10.1093/INFDIS/JIAF222en
dc.contributor.authorS Hillieren
dc.contributor.authorL Bekkeren
dc.contributor.authorS Riddleren
dc.contributor.authorCraig W Hendrixen
dc.contributor.authorSharlaa Badal-Faesenen
dc.contributor.authorE et al.en
dc.date.accessioned2026-03-23T10:23:12Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0022-1899en
dc.identifier.urihttps://hdl.handle.net/10539/48666
dc.journal.titleSafety Tolerability and Pharmacokinetics of OnceMonthly Oral Islatravir a Phase 2a Study in Participants at Low Risk for Acquiring HIV1en
dc.journal.volume232en
dc.publisherOXFORD UNIV PRESS INCen
dc.titleSafety Tolerability and Pharmacokinetics of OnceMonthly Oral Islatravir a Phase 2a Study in Participants at Low Risk for Acquiring HIV1en
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
722.1 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client